Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters

Abstract Effective vaccination strategies adaptable to emerging viruses like SARS-CoV-2 and capable of inducing robust protective immunity are needed. We evaluated the immunogenicity and protective efficacy of homologous and heterologous prime/boost regimens against SARS-CoV-2 in K18-hACE2 mice and...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Patricia Pérez, Kaijun Jiang, Irene González-Domínguez, Daniel Rodríguez-Martín, Adam Abdeljawad, Anastasija Cupic, Stefan Slamanig, Sara Flores, María A. Noriega, Pedro J. Sánchez-Cordón, Nicholas Lemus, Tsoi Ying Lai, Weina Sun, Mariano Esteban, Adolfo García-Sastre, Juan García-Arriaza
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Nature Portfolio 2025-11-01
Seri Bilgileri:	npj Vaccines
Online Erişim:	https://doi.org/10.1038/s41541-025-01299-3
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters

Benzer Materyaller